Juno Bio expands women’s health testing with $3.8M funding and a CLIA sequencing lab

Juno Bio raised $3.8 million and opened a CLIA-certified sequencing lab in Oakland, California, to scale its vaginal microbiome assay. The test analyzes roughly 10,000 bacteria and fungi plus four common sexually transmitted infections, and is available in 46 states, with the company citing more than 20,000 tests sold and ongoing pharmaceutical R&D partnerships.